Clinical Trials
176 trialsNCT02112565 2025-07-04
RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists
City of Hope Medical Center
Phase 1 Active not recruiting
NCT00483366 2024-09-23
Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors
University of Nebraska
Phase 1 Completed
NCT01206465 2023-12-26
Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors
University of Nebraska
Phase 1 Completed
NCT00084734 2023-08-04
Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors
Roswell Park Cancer Institute
Phase 1 Completed
NCT00936728 2023-02-01
White Wine or Nutritional Supplement in Improving Appetite in Patients With Cancer
Academic and Community Cancer Research United
Phase NA Completed
NCT02290522 2022-10-26
CoPPO
Rigshospitalet, Denmark
Phase NA Unknown
NCT01642342 2022-08-24
Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid Tumors
University of Southern California
Phase 1 Terminated
NCT01573780 2022-08-15
Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors
Roswell Park Cancer Institute
Phase 1 Terminated
NCT01527136 2022-07-22
Entolimod in Treating Patients With Locally Advanced or Metastatic Solid Tumors That Cannot Be Removed By Surgery
Roswell Park Cancer Institute
Phase 1 Completed
NCT01540253 2022-07-22
PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, Cannot Be Removed By Surgery, or Metastatic
Roswell Park Cancer Institute
Phase 1 Completed
NCT01828775 2021-03-10
Palliative Care Intervention in Improving Quality of Life, Psychological Distress, and Communication in Patients With Solid Tumors Receiving Treatment
City of Hope Medical Center
Phase NA Completed
NCT00914147 2021-03-08
Lung Function Testing in Patients With Locally Advanced or Metastatic Solid Tumors
Barbara Ann Karmanos Cancer Institute
Phase NA Completed
NCT00608933 2020-12-09
Education Intervention in Encouraging Health Providers to Talk With Cancer Patients About the Use of Complementary and Alternative Medicine
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00002950 2020-08-17
Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer
Yale University
Phase 1/2 Completed
NCT00091299 2020-08-05
Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors
Jonsson Comprehensive Cancer Center
Phase 1 Completed
NCT01470365 2020-05-08
3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Recurrent Tumors
Fox Chase Cancer Center
Phase 1 Completed
NCT01019187 2020-04-09
Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy
Abramson Cancer Center at Penn Medicine
Phase 2 Completed
NCT00645060 2020-02-27
Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A in Treating Patients With Advanced Solid Tumors
City of Hope Medical Center
Phase 1 Completed
NCT00004872 2019-12-13
Endostatin in Treating Patients With Advanced Refractory Solid Tumors
University of Wisconsin, Madison
Phase 1 Completed
NCT00005794 2019-12-13
Perifosine in Treating Patients With Advanced Solid Tumors
University of Wisconsin, Madison
Phase 1 Completed
NCT00023855 2019-12-13
PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors
University of Wisconsin, Madison
Phase 1 Completed
NCT02146222 2019-11-18
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors
University of Wisconsin, Madison
Phase 1 Completed
NCT01791088 2019-04-22
Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery
University of Chicago
Phase 1 Completed
NCT00909831 2019-04-16
Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT00390000 2019-04-08
Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors
Mayo Clinic
Phase 1 Completed
NCT00002902 2019-03-13
Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT01713972 2019-03-01
Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors
Ohio State University Comprehensive Cancer Center
Phase 1 Completed
NCT02070406 2019-02-28
Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies
Jonsson Comprehensive Cancer Center
Phase 1 Terminated
NCT00892385 2019-02-22
Methoxyamine and Temozolomide in Treating Patients With Advanced Solid Tumors
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00096317 2018-10-31
Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors
Montefiore Medical Center
Phase 1 Completed
NCT00004863 2018-09-10
Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors
Montefiore Medical Center
Phase 1 Completed
NCT00004864 2018-09-10
Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors
Montefiore Medical Center
Phase 1 Completed
NCT01705106 2018-05-30
Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies
University of Chicago
Phase 1 Terminated
NCT00290680 2018-04-10
Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors
Medical University of South Carolina
Phase 1 Completed
NCT00014261 2018-03-30
Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors
Dartmouth-Hitchcock Medical Center
Phase 1 Completed
NCT01566279 2018-03-09
CPCT-03
UMC Utrecht
Phase NA Completed
NCT00810394 2018-01-10
Sorafenib in Treating Patients With Advanced Malignant Solid Tumors
University of California, Davis
Phase 2 Completed
NCT00098514 2017-12-18
Talotrexin in Treating Patients With Advanced or Recurrent Solid Tumors
Dana-Farber Cancer Institute
Phase 1 Completed
NCT00541359 2017-08-09
Bortezomib and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors
City of Hope Medical Center
Phase 1 Completed
NCT00471562 2017-08-01
Angiotensin-(1-7) in Treating Patients With Metastatic or Unresectable Solid Tumors
Wake Forest University Health Sciences
Phase 1 Completed
NCT00610948 2017-05-04
Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT01957995 2017-04-11
Nanosomal Docetaxel Lipid Suspension in Treating Patients With Advanced Solid Tumors
University of Southern California
Phase 1 Completed
NCT00217490 2017-04-04
Individual Counseling and/or Computer-Based Counseling in Helping Healthy Women Adopt a Cancer Prevention Diet
Kaiser Permanente
Phase NA Completed
NCT01098643 2017-04-04
Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors
Vanderbilt University Medical Center
Phase NA Terminated
NCT00731276 2017-03-31
Irinotecan in Treating Asian Patients With Solid Tumors
National Cancer Centre, Singapore
Phase 1 Completed
NCT00878904 2017-03-24
Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors
University of California, San Francisco
Phase 1 Completed
NCT00662636 2017-03-23
Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery
Mayo Clinic
Phase 1 Completed
NCT00091247 2017-03-16
Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer
Alliance for Clinical Trials in Oncology
Phase NA Completed
NCT00311597 2017-03-14
Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors
Wake Forest University Health Sciences
Phase 1/2 Completed
NCT00607802 2017-01-19
Donor White Blood Cell Infusion in Treating Patients With Metastatic or Unresectable Cancer
Wake Forest University Health Sciences
Phase NA Withdrawn